Study Atlas
Study accountPrivacySaved locally

Pediatrics

Galactosemia

A newborn becomes ill after milk feeds. Jaundice, liver dysfunction and cataracts point toward impaired galactose metabolism.

Core Understanding21 min lesson estimate29 question families

Partially covered in the main question banks · 4 main-bank entries · 23 linked PDF entries · 4 generated drills

Prerequisites and related lessons
  • Neonatal cholestasis

Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, p. 277. Lesson adapted from Pediatric hepatology and metabolic disease.

Topic map

  • Lactoseglucose + galactose
  • GALT deficiencyGal-1-P and galactitol build up
  • Neonateliver injury, cataracts, sepsis risk
  • Actrestrict galactose immediately and confirm

Scroll the diagram to see all labels.

Galactose metabolism in classic galactosemiaGALT normally moves galactose-1-phosphate into the UDP-sugar pathway. A block increases Gal-1-P and diverts galactose toward galactitol. LactoseGalactoseGal-1-PUDP-galactose GALT block Galactitol in lensGal-1-P accumulatesCataractsHepatic and systemic injury
Galactose metabolism in classic galactosemiaGALT normally moves galactose-1-phosphate into the UDP-sugar pathway. A block increases Gal-1-P and diverts galactose toward galactitol.

Definition and biochemical pathway

Classic galactosemia is an autosomal recessive [Pediatric Mid Gal Q1] disorder due to severe deficiency of galactose-1-phosphate uridylyltransferase (GALT) [Pediatric Mid Gal Q2/Q10/Q12 · IRAT case 2]. Lactase splits the lactose in breast milk or standard formula into glucose and galactose. Galactokinase forms galactose-1-phosphate. GALT normally transfers a uridyl group from UDP-glucose, producing UDP-galactose and glucose-1-phosphate. This allows galactose carbon to enter ordinary carbohydrate metabolism. UDP-galactose 4-epimerase interconverts UDP-galactose and UDP-glucose.

With GALT deficiency, galactose-1-phosphate [Pediatric Mid Gal Q13] accumulates, and aldose reductase converts excess galactose into galactitol. Galactitol traps water in the lens, producing cataracts [Pediatric Mid Gal Q4/Q10/Q19]. The major organs at risk are liver, brain, kidneys and eyes [Pediatric Mid Gal Q3]. GALK1 deficiency often presents chiefly with cataracts. GALE deficiency varies by subtype. Duarte-related biochemical findings require specific interpretation and differ from severe classic disease.

Presentation and complications

Symptoms often start within a few days of starting milk feeds [Pediatric Mid Gal Q4–5/Q10]. Look for poor feeding, vomiting and diarrhea [Pediatric Mid Gal Q6], jaundice, hepatomegaly, poor weight gain and liver dysfunction with coagulopathy [Pediatric Mid Gal Q7–8/Q17]. Lethargy, irritability and hypotonia can accompany metabolic decompensation. Check glucose because hypoglycemia [IRAT case 2] may be severe. Complications include liver failure, bleeding, renal tubular dysfunction and E. coli sepsis [Pediatric Mid Gal Q18 · IRAT case 2]. An ill infant can have both metabolic disease and sepsis, so investigate both promptly.

TBL/IRAT case 2 presents at eight days after exclusive breastfeeding with glucose 42 mg/dL, total bilirubin 18.5 mg/dL, direct bilirubin 9.2 mg/dL, hepatomegaly, hypotonia and prolonged PT/INR. That pattern supports a systemic neonatal disorder rather than benign breast milk jaundice. An absent cataract does not rule it out.

Screening and confirmation

Initial assessment
Suspect from milk-triggered neonatal illness or a positive screen
Confirmation or next test
Erythrocyte GALT activity and/or molecular testing; start dietary restriction promptly when suspected

Newborn screening may detect increased total galactose or reduced GALT activity [Pediatric Mid Gal Q11], depending on the program. Confirm with erythrocyte GALT activity and/or molecular testing for disease-causing GALT variants [Pediatric Mid Gal Q12]. Elevated erythrocyte galactose-1-phosphate supports the diagnosis. Transfused cells can alter activity testing, so coordinate specimen choice with the metabolic team. Urine reducing substances are nonspecific and can disappear after dietary restriction. Also assess glucose, bilirubin fractions, liver tests, coagulation, renal function and possible infection.

Immediate treatment and follow-up

In a strongly suggestive symptomatic infant, stop breast milk and ordinary lactose-containing formula and start a galactose-restricted diet without waiting for confirmation [Pediatric Mid Gal Q14–16 · IRAT case 2]. Use a metabolic-team-approved option, such as suitable soy-based or elemental formula. The exam says lactose-free formula. Check actual galactose content and clinical suitability because lactose-free dairy can still contain free galactose.

Stabilize airway and circulation as indicated, correct hypoglycemia and dehydration, obtain cultures and treat suspected neonatal sepsis promptly. Assess liver failure, give vitamin K if indicated and discuss severe bleeding/coagulopathy with the treating team. Plasma is reserved for indications such as significant bleeding or selected procedures. Refer urgently to metabolic and hepatology specialists. Continue long-term restricted dairy galactose under a metabolic dietitian, with adequate calcium and vitamin D. Dietary treatment prevents much early toxicity, while speech, learning and developmental difficulties [Pediatric Mid Gal Q20–21], movement problems and premature ovarian insufficiency can occur despite early treatment. Monitor growth, neurodevelopment, bone health and pubertal/ovarian function.

Exam traps

Classic disease appears after exposure to lactose in breast milk or ordinary formula. Hereditary fructose intolerance generally becomes evident after fructose, sucrose or sorbitol exposure. CMPA targets milk protein and does not account for the characteristic combination of cataracts and severe metabolic liver injury. Changing diet promptly and verifying the diagnosis are parallel steps.

Diagnostic and management pathways

  • Ill neonate after milk with jaundice, vomiting or cataract → stabilize and evaluate for sepsis and liver failure
  • Strong suspicion → immediately begin an appropriate galactose-restricted feed
  • Confirm with erythrocyte GALT activity and/or molecular studies; assess Gal-1-P
  • Long-term → metabolic diet, nutrition and surveillance of development and ovarian/bone health

Compare at a glance

ConditionDistinguishing clueInvestigation or first action
Classic galactosemiaMilk-triggered illness, hepatomegaly, cataract or sepsisRestrict galactose urgently and assess GALT
GALK1 deficiencyCataracts with less typical systemic liver injuryEnzyme and molecular evaluation
Hereditary fructose intoleranceSymptoms after fructose/sucrose introductionALDOB-focused evaluation
Breast milk jaundiceThriving infant, predominantly unconjugated bilirubinAssess fractions and clinical context
Neonatal sepsisIllness and possible cholestasis, with or without a metabolic causeCultures and prompt sepsis treatment

Supplementary clarification – not directly stated in the uploaded materials. Clinical references · GalNet classic galactosemia clinical guideline

Exam words

  • autosomal recessive [Pediatric Mid Gal Q1]
  • galactose-1-phosphate uridylyltransferase (GALT) [Pediatric Mid Gal Q2/Q10/Q12 · IRAT case 2]
  • galactose-1-phosphate [Pediatric Mid Gal Q13]
  • cataracts [Pediatric Mid Gal Q4/Q10/Q19]
  • liver, brain, kidneys and eyes [Pediatric Mid Gal Q3]
  • within a few days of starting milk feeds [Pediatric Mid Gal Q4–5/Q10]
  • poor feeding, vomiting and diarrhea [Pediatric Mid Gal Q6]
  • liver dysfunction with coagulopathy [Pediatric Mid Gal Q7–8/Q17]
  • hypoglycemia [IRAT case 2]
  • E. coli sepsis [Pediatric Mid Gal Q18 · IRAT case 2]
  • increased total galactose or reduced GALT activity [Pediatric Mid Gal Q11]
  • GALT variants [Pediatric Mid Gal Q12]
  • stop breast milk and ordinary lactose-containing formula and start a galactose-restricted diet without waiting for confirmation [Pediatric Mid Gal Q14–16 · IRAT case 2]
  • speech, learning and developmental difficulties [Pediatric Mid Gal Q20–21]

Practice questions

Rapid revision sheet

Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.

  • autosomal recessive [Pediatric Mid Gal Q1]
  • galactose-1-phosphate uridylyltransferase (GALT) [Pediatric Mid Gal Q2/Q10/Q12 · IRAT case 2]
  • galactose-1-phosphate [Pediatric Mid Gal Q13]
  • cataracts [Pediatric Mid Gal Q4/Q10/Q19]
  • liver, brain, kidneys and eyes [Pediatric Mid Gal Q3]
  • within a few days of starting milk feeds [Pediatric Mid Gal Q4–5/Q10]

Official College Textbook – Digestive Disorders – Part 1, p. 277

Active recall

A neonate develops jaundice, poor feeding and hepatomegaly after milk feeds. What enzyme is deficient in classic galactosemia?

Galactose-1-phosphate uridylyltransferase (GALT). Prompt metabolic assessment and a suitable galactose-restricted feed are important.

Official College Textbook – Digestive Disorders – Part 1, p. 277

Recall the diagnostic and management pathway from memory.

Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.

  • Ill neonate after milk with jaundice, vomiting or cataract → stabilize and evaluate for sepsis and liver failure
  • Strong suspicion → immediately begin an appropriate galactose-restricted feed
  • Confirm with erythrocyte GALT activity and/or molecular studies; assess Gal-1-P
  • Long-term → metabolic diet, nutrition and surveillance of development and ovarian/bone health
↑